]>
IRCT20200127046282N18 IRCT 2022-06-05 Skin and Stem cell Research Center of Tehran University of Medical Sciences Evaluation the efficacy of stem cells condition medium on hair transplantation outcome Evaluation the efficacy of mesenchymal stem cells condition medium on hair transplantation outcome 2022-06-20 anticipated 30 Complete https://irct.ir/trial/62665 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: Patients participating in this study and analyzing the data are unaware of the study groups. Therefore, the study will be double-blind. 1-2 Hair loss. Intervention 1: Intervention group: Two weeks after the hair transplant, 3 cc stem cells condition medium is injected subcutaneously five times every two weeks at the transplant site and sprayed a little. Intervention 2: Control group: Two weeks after the hair transplant, 3 cc platelet rich plasma is injected subcutaneously five times every two weeks at the transplant site and sprayed a little. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is -
public Sona Zare
No 4, Maryam Alley, South Kamraniyeh Street, Tehran, Iran
Tehran Iran (Islamic Republic of) 1937957511 +98 21 2665 7438 sonazarebio@gmail.com Skin and Stem cell Research Center of Tehran University of Medical Sciences scientific Mohammad Ali Nilforoushzadeh
No 4, Maryam Alley, South Kamraniyeh Street, Tehran, Iran
Tehran Iran (Islamic Republic of) 1937957511 +98 21 2665 7438 Dr_nilforoush@yahoo.com Skin and Stem cell Research Center of Tehran University of Medical Sciences Iran (Islamic Republic of) Candidate hair transplant patients Absence of internal diseases except hypothyroidism Do not take drugs that cause hair loss such as chemotherapy, psychotropic drugs, anticoagulants, cardiovascular, retinoids, antimicrobials, androgen hormones Absence of psychiatric diseases such as obsessive-compulsive disorder and trichotillomania Absence of active infection in the transplanted area Age between 18-50 years 18 years 50 years Both Reluctance to continue cooperation Pregnancy Breastfeeding Exposure to acute and severe stress during the study Allergy to xylocaine L65.9 Nonscarring hair loss, unspecified Treatment - Other Treatment - Other Intervention group: Two weeks after the hair transplant, 3 cc stem cells condition medium is injected subcutaneously five times every two weeks at the transplant site and sprayed a little. Control group: Two weeks after the hair transplant, 3 cc platelet rich plasma is injected subcutaneously five times every two weeks at the transplant site and sprayed a little. Hair recovery rate. Timepoint: Before treatment and six months after the last session. Method of measurement: Trichoscan. Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit. Skin and Stem cell Research Center of Tehran University of Medical Sciences Approved 2022-02-16 Research Ethics Committee of Tehran University of Medical Sciences Keshavarz blvd, Tehran University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)